15,969
Total Claims
$945K
Drug Cost
1,783
Beneficiaries
$530
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-97%
Opioid rate vs peers
0.1% vs 2.6% avg
-50%
Cost per patient vs peers
$530 vs $1,068 avg
-20%
Brand preference vs peers
7.2% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$148
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
93% generic
Brand: 1,142 claims · $786K
Generic: 14,753 claims · $154K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 141 | $158K |
| Canagliflozin | 70 | $69K |
| Insulin Degludec | 60 | $52K |
| Insulin Degludec | 49 | $50K |
| Sitagliptin Phosphate | 39 | $38K |
| Semaglutide | 21 | $32K |
| Empagliflozin | 16 | $29K |
| Budesonide/Formoterol Fumarate | 29 | $29K |
| Fluticasone/Umeclidin/Vilanter | 21 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $17K |
| Mirabegron | 12 | $16K |
| Albuterol Sulfate | 195 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $12K |
| Insulin Aspart | 21 | $11K |
| Fluticasone Propionate | 11 | $9,799 |
Prescribing Profile
Patient Profile
72
Avg Age
53%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data